Status:
COMPLETED
National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Cytopenia
Autoimmune Haemolytic Anaemia
Eligibility:
All Genders
Up to 18 years
Brief Summary
This study aims to study prospectively the clinical and paraclinical evolution and prognostic factors of autoimmune haemolytic anemias, Evans syndromes and chronic immunological thrombocytopenic purpu...
Detailed Description
These autoimmune haematological diseases are rare diseases affecting the child, often very young, and serious and potentially life-threatening. International literature data are scarce, and include in...
Eligibility Criteria
Inclusion
- Age strictly below 18 years of age at initial diagnosis
- Affiliate child or beneficiary of a social security scheme
- Child residing in metropolitan France
- Diagnosis of autoimmune haemolytic anemias, Evans syndrome and / or chronic Immune thrombocytopenic purpura
- Free, informed, written and signed consent
Exclusion
- Diagnosis of constitutional haemolytic anemia
- Diagnosis of platelet constitutional disease
Key Trial Info
Start Date :
April 4 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 8 2012
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT04070612
Start Date
April 4 2007
End Date
June 8 2012
Last Update
August 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.